Mucosal transmission of HIV involves a strong bottleneck effect and most often, a single founder virus is transmitted. The relative contributions of stochastic (random) selection vs. active selection by specific viral and host characteristics to this bottleneck are unclear. Mother-to-child HIV-1 transmission (MTCT) through breastfeeding, in which transmission pairs and timing of infant infection are readily identified, provides an instructive model to address these important and unresolved questions. We will use serial samples from a large, well characterized cohort of HIV-1 infected Zimbabwean women who transmitted HIV-1 through breastmilk. This cohort includes women with chronic HIV-1 infection (CI;N=35), and women who acquired primary HIV-1 infection post-partum (acute infection, AI;N=13). We combine phylogenetics (with frequency analyses based on deep sequencing data) with functional assays (CD4 and co-receptor use, entry kinetics, neutralization sensitivity), to quantitatively and comprehensively analyze the relationship of founder viruses to maternal blood or breastmilk variants, quantify the relative contributions of stochastic vs. active selectio, identify selection pressures on envelope (env), differentiate when selection pressures may operate during the transmission bottleneck, and determine whether founder env variants are better adapted than other non- transmitted variants for postnatal MTCT. Delineation of the biologic properties of transmitted variants along with mapping the genetic bases of these biologic properties, should improve understanding of HIV-1 entry and the mechanisms of action of HIV-1 entry inhibitors. These studies will also improve our understanding of the in vivo selective pressures exerted by autologous neutralizing antibodies and innate factors in two distinct and relevant anatomic compartments (blood, where levels of antibodies are high, and breastmilk, where they are much lower) and the potential role of neutralization sensitivity or escape in transmission. Finally, these studies will specifically reveal whether increasing the neutralizing activity of blood or breastmilk (e.g., through passive or active immunization) or targeting other Env functional properties (tropism, infectivity) hold promise to block primary infection of women and children.

Public Health Relevance

This proposal will use state-of-the-art, high-throughput sequencing and functional assays to examine the genetic diversity, evolution, and transmission-related biology of the HIV-1 Envelope protein. Understanding the genetics and transmission-related biology of early HIV-1 env variants should allow the development of improved strategies to block primary HIV-1 infection of women and children.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
1R01AI097265-01A1
Application #
8329143
Study Section
AIDS Clinical Studies and Epidemiology Study Section (ACE)
Program Officer
Sharma, Opendra K
Project Start
2012-02-09
Project End
2017-01-31
Budget Start
2012-02-09
Budget End
2013-01-31
Support Year
1
Fiscal Year
2012
Total Cost
$848,885
Indirect Cost
$198,529
Name
University of Massachusetts Medical School Worcester
Department
Pediatrics
Type
Schools of Medicine
DUNS #
603847393
City
Worcester
State
MA
Country
United States
Zip Code
01655
Janoff, Edward N (2017) The microbiome and human disease pathogenesis: how do you do what you do to me …? Transl Res 179:1-6
Sanborn, Keri B; Somasundaran, Mohan; Luzuriaga, Katherine et al. (2015) Recombination elevates the effective evolutionary rate and facilitates the establishment of HIV-1 infection in infants after mother-to-child transmission. Retrovirology 12:96
Luzuriaga, Katherine; Gay, Hannah; Ziemniak, Carrie et al. (2015) Viremic relapse after HIV-1 remission in a perinatally infected child. N Engl J Med 372:786-8
Shen, Ruizhong; Achenbach, Jenna; Shen, Yue et al. (2015) Mother-to-Child HIV-1 Transmission Events Are Differentially Impacted by Breast Milk and Its Components from HIV-1-Infected Women. PLoS One 10:e0145150
Gustafson, C E; Higbee, D; Yeckes, A R et al. (2014) Limited expression of APRIL and its receptors prior to intestinal IgA plasma cell development during human infancy. Mucosal Immunol 7:467-77
Janoff, E N; Rubins, J B; Fasching, C et al. (2014) Pneumococcal IgA1 protease subverts specific protection by human IgA1. Mucosal Immunol 7:249-56
Palaia, Jana M; McConnell, Michelle; Achenbach, Jenna E et al. (2014) Neutralization of HIV subtypes A and D by breast milk IgG from women with HIV infection in Uganda. J Infect 68:264-72
Pujanauski, Lindsey M; Janoff, Edward N; McCarter, Martin D et al. (2013) Mouse marginal zone B cells harbor specificities similar to human broadly neutralizing HIV antibodies. Proc Natl Acad Sci U S A 110:1422-7
Frank, Daniel N; Manigart, Olivier; Leroy, Valériane et al. (2012) Altered vaginal microbiota are associated with perinatal mother-to-child transmission of HIV in African women from Burkina Faso. J Acquir Immune Defic Syndr 60:299-306